ProCE Banner Activity

Individualizing the Current Adjuvant Therapy Algorithm for Patients With HR+/HER2- EBC

Slideset

Download these slides covering the latest evidence and recommendations on how to individualize current adjuvant therapy for patients with HR+/HER2- EBC.

Released: December 06, 2024

Expiration: December 05, 2025

Share

Faculty

William J. Gradishar

William J. Gradishar, MD, FACP, FASCO

Betsy Bramsen Professor of Breast Oncology
Robert H. Lurie Comprehensive Cancer Center
Northwestern University
Chicago, Illinois

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from Lilly and Novartis Pharmaceuticals Corporation.

Lilly

Novartis Pharmaceuticals Corporation